Blog

Mr. Moraitis brings over 25 years of experience in strategic planning, operations, and business development within the pharmaceutical sector. In his new role, he will be responsible for driving strategic initiatives and optimizing operational processes to support Cosmos Health’s mission of delivering innovative pharmaceutical solutions globally.

Throughout his distinguished career, Mr. Moraitis has held key leadership positions at major pharmaceutical companies, including DEMO, MENARINI, the VIANEX Group, and TIKUN OLAM Europe. He has played a pivotal role in shaping industry strategies and driving business growth in the pharmaceutical sector.

In addition, Mr. Moraitis has served as both a leader and board member of several prominent pharmaceutical associations, including AESGP (Association of the European Self-Care Industry), the leading European association representing manufacturers of non-prescription medicines, food supplements, and self-care medical devices; ΕfEX (Hellenic Association of Self-Care Products), the Greek association promoting self-care solutions and OTC healthcare products; SEPTΕDE (Association of Enterprises for Infant Nutrition & Special Dietary Products of Greece), focusing on the regulation and development of infant nutrition and special dietary products; and SAFFE (Hellenic Association of Pharmaceutical Enterprises & Representatives), an influential organization representing pharmaceutical enterprises and their contributions to the Greek market.

Dimitris Moraitis expressed his enthusiasm about joining Cosmos Health: “I am honored to be part of Cosmos, a company dedicated to advancing pharmaceutical innovation. Greg Siokas is a visionary leader with a forward-thinking approach, and I look forward to applying my experience to support the Company’s growth strategy and contribute to the development of innovative solutions that enhance patient care worldwide.”

Greg Siokas, CEO of Cosmos Health, stated: “We are thrilled to welcome Dimitris to our management team. His extensive experience and deep understanding of the pharmaceutical industry make him an invaluable addition. I have absolute confidence in his ability to lead our strategic and operational initiatives as we continue to expand our global footprint.”

Πηγή: finance.yahoo.com